-+ 0.00%
-+ 0.00%
-+ 0.00%

Wacker Chemie (XTRA:WCH) Could Be 8% Overvalued After Half Year Earnings

Simply Wall St·08/06/2026 18:41:43
Listen to the news

Why Wacker Chemie Stock Is Back On Investors’ Radar

Wacker Chemie (XTRA:WCH) has drawn fresh attention after reporting half year 2026 earnings. Sales reached €2,923.2 million and the company moved from a prior net loss to net income of €351.2 million.

See our latest analysis for Wacker Chemie.

The latest half year earnings appear to have acted as a fresh catalyst for Wacker Chemie, with the stock recording a 7 day share price return of 11.52% and a year to date share price return of 34.15%. The 1 year total shareholder return of 45.56% contrasts with weaker 3 and 5 year total shareholder returns, which indicates recent momentum has picked up after a tougher stretch for longer term holders.

If this kind of earnings driven move has your attention, it can be a good moment to widen your opportunity set and check out 108 top founder-led companies

Bulls see Wacker Chemie’s swing back to profit and sharp share price gains as the start of a sustained reset. Bears, meanwhile, point to weaker multi year returns. Which side does the current valuation support?

Most Popular Narrative: 8% Overvalued

The most followed narrative puts Wacker Chemie’s fair value at €88.97, which sits below the recent close at €95.85. That gap reflects a fairly tight, but still cautious, view on upside from here.

Completion of major strategic investments and new polysilicon and specialty chemicals capacities positions Wacker to benefit long term from rising demand in renewable energy (solar and battery storage) and advanced electronics, likely supporting higher revenue growth and operational leverage once demand recovers.

Read the complete narrative.

The valuation story here leans heavily on a reset in margins and a step up in earnings power. It assumes steadier revenue growth, improving profitability and a richer future earnings multiple all working together. It is worth examining which of those levers does the heavy lifting in the model, and how far they are pushed.

Result: Fair Value of €88.97 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Wacker Chemie still faces pressure from polysilicon overcapacity and currency swings, which could hit margins and challenge the current earnings reset narrative.

Find out about the key risks to this Wacker Chemie narrative.

Another View On Wacker Chemie’s Value

The analyst narrative sees Wacker Chemie as about 8% overvalued at €88.97 versus the current €95.85, yet Simply Wall St’s DCF model points in the opposite direction. On that view, the stock trades at about 76% below an estimated future cash flow value of €395.98. Which set of assumptions feels more realistic to you?

For a closer look at how this gap comes about, it helps to see the full SWS DCF model in action. Look into how the SWS DCF model arrives at its fair value.

WCH Discounted Cash Flow as at Aug 2026
WCH Discounted Cash Flow as at Aug 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Wacker Chemie for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 255 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment on Wacker Chemie clearly split, this is a good moment to act quickly and compare the numbers to your own expectations. To see what is driving optimism, take a closer look at the 2 key rewards

Looking For More Investment Ideas Beyond Wacker Chemie?

If Wacker Chemie has sharpened your focus, use this momentum to uncover other opportunities where quality, income, or resilience might better match your goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.